Viveve Medical Inc
Viveve develops and sells healthcare-focused human resources (HR) software solutions designed to streamline and unify HR operations for healthcare organizations. It offers an all-in-one platform that supports recruitment, employee management, and attendance management, aiming to reduce administrative burden and enhance the employee experience throughout their career lifecycle. The company also pr… Read more
Viveve Medical Inc (VIVE) - Net Assets
Latest net assets as of September 2022: $1.18 Million USD
Based on the latest financial reports, Viveve Medical Inc (VIVE) has net assets worth $1.18 Million USD as of September 2022.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.15 Million) and total liabilities ($10.97 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.18 Million |
| % of Total Assets | 9.74% |
| Annual Growth Rate | 4.52% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 102.48 |
Viveve Medical Inc - Net Assets Trend (1991–2021)
This chart illustrates how Viveve Medical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Viveve Medical Inc (1991–2021)
The table below shows the annual net assets of Viveve Medical Inc from 1991 to 2021.
| Year | Net Assets | Change |
|---|---|---|
| 2021-12-31 | $15.07 Million | +116.03% |
| 2020-12-31 | $6.97 Million | -57.79% |
| 2019-12-31 | $16.52 Million | +236.34% |
| 2018-12-31 | $4.91 Million | +288.92% |
| 2017-12-31 | $-2.60 Million | -541.98% |
| 2016-12-31 | $-405.00K | -110.29% |
| 2015-12-31 | $3.94 Million | +568.01% |
| 2014-12-31 | $-841.00K | +87.34% |
| 2013-12-31 | $-6.64 Million | +44.40% |
| 2012-12-31 | $-11.95 Million | -192.25% |
| 2011-12-31 | $-4.09 Million | -385.08% |
| 2010-12-31 | $1.43 Million | -17.06% |
| 2009-12-31 | $1.73 Million | -45.82% |
| 2008-12-31 | $3.19 Million | -35.54% |
| 2007-12-31 | $4.95 Million | -30.57% |
| 2006-12-31 | $7.13 Million | +28.61% |
| 2005-12-31 | $5.54 Million | -18.83% |
| 2004-12-31 | $6.83 Million | -9.62% |
| 2003-12-31 | $7.56 Million | +12.36% |
| 2002-12-31 | $6.72 Million | +6.58% |
| 2001-12-31 | $6.31 Million | +1.51% |
| 2000-12-31 | $6.22 Million | -30.04% |
| 1999-12-31 | $8.88 Million | -16.96% |
| 1998-12-31 | $10.70 Million | -43.68% |
| 1997-12-31 | $19.00 Million | +15.15% |
| 1996-12-31 | $16.50 Million | +6.45% |
| 1995-12-31 | $15.50 Million | +18.32% |
| 1994-12-31 | $13.10 Million | +95.52% |
| 1993-12-31 | $6.70 Million | +24.07% |
| 1992-12-31 | $5.40 Million | +35.00% |
| 1991-12-31 | $4.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Viveve Medical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 24135300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2021)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $1.00K | 0.01% |
| Other Components | $256.92 Million | 1705.28% |
| Total Equity | $15.07 Million | 100.00% |
Viveve Medical Inc Competitors by Market Cap
The table below lists competitors of Viveve Medical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LETSHEGO HOLDINGS LIMITED
XBOT:LLR-EQU
|
$2.15K |
|
CH HS TRANSMIS EQUI - Dusseldorf Stock Exchang
DU:BGR
|
$2.15K |
|
Strategie Kapital AG
DU:S14
|
$2.15K |
|
POCML 7 Inc.
V:POC-P
|
$2.16K |
|
Pan Asia Banking Corporation PLC
CM:PABCN0000
|
$2.14K |
|
Trans Asia Hotels PLC
CM:TRANN0000
|
$2.14K |
|
Bank Makramah
KAR:BML
|
$2.14K |
|
East Star Resources PLC
LSE:EST
|
$2.14K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Viveve Medical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2020 to 2021, total equity changed from 6,974,000 to 15,066,000, a change of 8,092,000 (116.0%).
- Net loss of 22,027,000 reduced equity.
- Dividend payments of 4,685,000 reduced retained earnings.
- Share repurchases of 704,000 reduced equity.
- New share issuances of 25,826,000 increased equity.
- Other factors increased equity by 9,682,000.
Equity Change Factors (2020 to 2021)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-22.03 Million | -146.2% |
| Dividends Paid | $4.68 Million | -31.1% |
| Share Repurchases | $704.00K | -4.67% |
| Share Issuances | $25.83 Million | +171.42% |
| Other Changes | $9.68 Million | +64.26% |
| Total Change | $- | 116.03% |
Book Value vs Market Value Analysis
This analysis compares Viveve Medical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1990-12-31 | $-41666.67 | $0.00 | x |
| 1991-12-31 | $333333.33 | $0.00 | x |
| 1992-12-31 | $360000.00 | $0.00 | x |
| 1993-12-31 | $418750.00 | $0.00 | x |
| 1994-12-31 | $689473.68 | $0.00 | x |
| 1995-12-31 | $815789.47 | $0.00 | x |
| 1996-12-31 | $825000.00 | $0.00 | x |
| 1997-12-31 | $826086.96 | $0.00 | x |
| 1998-12-31 | $428000.00 | $0.00 | x |
| 1999-12-31 | $341730.77 | $0.00 | x |
| 2000-12-31 | $214344.83 | $0.00 | x |
| 2001-12-31 | $175277.78 | $0.00 | x |
| 2002-12-31 | $181756.76 | $0.00 | x |
| 2003-12-31 | $204216.22 | $0.00 | x |
| 2004-12-31 | $184567.57 | $0.00 | x |
| 2005-12-31 | $149810.81 | $0.00 | x |
| 2006-12-31 | $192675.68 | $0.00 | x |
| 2007-12-31 | $133783.78 | $0.00 | x |
| 2008-12-31 | $86243.24 | $0.00 | x |
| 2009-12-31 | $46729.73 | $0.00 | x |
| 2010-12-31 | $38756.76 | $0.00 | x |
| 2011-12-31 | $-110486.49 | $0.00 | x |
| 2012-12-31 | $-298675.00 | $0.00 | x |
| 2013-12-31 | $-42576.92 | $0.00 | x |
| 2014-12-31 | $-373.45 | $0.00 | x |
| 2015-12-31 | $783.75 | $0.00 | x |
| 2016-12-31 | $-43.92 | $0.00 | x |
| 2017-12-31 | $-148.61 | $0.00 | x |
| 2018-12-31 | $158.15 | $0.00 | x |
| 2019-12-31 | $43.11 | $0.00 | x |
| 2020-12-31 | $4.43 | $0.00 | x |
| 2021-12-31 | $1.49 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Viveve Medical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -146.20%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -342.78%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 1.72x
- Recent ROE (-146.20%) is below the historical average (-106.79%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1990 | 0.00% | -100.00% | 0.00x | 0.00x | $-50.00K |
| 1991 | -57.50% | -2300.00% | 0.02x | 1.33x | $-2.70 Million |
| 1992 | -520.37% | -1170.83% | 0.35x | 1.26x | $-28.64 Million |
| 1993 | -59.70% | -121.21% | 0.43x | 1.13x | $-4.67 Million |
| 1994 | -19.85% | -50.00% | 0.36x | 1.09x | $-3.91 Million |
| 1995 | 12.90% | 15.04% | 0.73x | 1.18x | $450.00K |
| 1996 | -9.09% | -12.61% | 0.61x | 1.18x | $-3.15 Million |
| 1997 | -75.79% | -161.80% | 0.33x | 1.42x | $-16.30 Million |
| 1998 | -155.14% | -291.23% | 0.35x | 1.52x | $-17.67 Million |
| 1999 | -73.78% | -56.33% | 0.76x | 1.72x | $-7.44 Million |
| 2000 | -119.21% | -72.36% | 0.68x | 2.43x | $-8.03 Million |
| 2001 | -61.84% | -39.90% | 0.80x | 1.95x | $-4.53 Million |
| 2002 | 4.54% | 3.45% | 0.86x | 1.54x | $-367.50K |
| 2003 | 6.84% | 6.20% | 0.85x | 1.30x | $-238.60K |
| 2004 | -12.20% | -11.00% | 0.57x | 1.95x | $-1.52 Million |
| 2005 | -22.88% | -16.61% | 0.61x | 2.25x | $-1.82 Million |
| 2006 | 18.50% | 18.46% | 0.54x | 1.85x | $606.10K |
| 2007 | -47.82% | -39.42% | 0.54x | 2.26x | $-2.86 Million |
| 2008 | -60.80% | -36.40% | 0.67x | 2.48x | $-2.26 Million |
| 2009 | -94.04% | -34.51% | 0.93x | 2.92x | $-1.80 Million |
| 2010 | -35.22% | -12.92% | 1.18x | 2.31x | $-648.40K |
| 2011 | 0.00% | -858.12% | 0.19x | 0.00x | $-5.35 Million |
| 2012 | 0.00% | -776.57% | 0.99x | 0.00x | $-7.19 Million |
| 2013 | 0.00% | 274.65% | 0.82x | 0.00x | $4.16 Million |
| 2014 | 0.00% | -6866.67% | 0.04x | 0.00x | $-6.10 Million |
| 2015 | -315.70% | -858.74% | 0.13x | 2.92x | $-12.82 Million |
| 2016 | 0.00% | -281.63% | 0.49x | 0.00x | $-20.07 Million |
| 2017 | 0.00% | -239.60% | 0.42x | 0.00x | $-36.37 Million |
| 2018 | -1001.26% | -265.60% | 0.40x | 9.53x | $-49.67 Million |
| 2019 | -257.41% | -647.57% | 0.24x | 1.63x | $-44.18 Million |
| 2020 | -314.24% | -399.98% | 0.33x | 2.38x | $-22.61 Million |
| 2021 | -146.20% | -342.78% | 0.25x | 1.72x | $-23.53 Million |
Industry Comparison
This section compares Viveve Medical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Viveve Medical Inc (VIVE) | $1.18 Million | 0.00% | 9.27x | $2.14K |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |